文献速递病毒性肝炎艾滋病与性传播感染

阿片类药物治疗项目中丙型肝炎病毒照护连续结局与社区病毒载量

Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
PubMed 文献 · J Infect Dis · 2020-01-01

该研究利用2013-2016年阿片类药物治疗项目患者数据,分析HCV抗体及病毒载量检测、照护链接和治疗比例,并计算社区病毒载量及未满足治疗需求。实施反射性定性病毒载量检测后,照护连续结局显著改善,但未满足治疗需求仍高。

要点

  • 实施反射性定性HCV病毒载量检测后,抗体检测、照护链接和治疗比例均显著上升。
  • 西班牙裔与较低照护链接相关,曼哈顿居住与改善的照护链接相关。
  • documented和估计的未满足治疗需求下降但仍高,需扩大治疗覆盖。

核心结论

  • 实施反射性定性病毒载量检测后HCV照护连续结局改善,但差距仍存,未满足治疗需求高。

主要发现

  • HCV抗体检测比例从2013-2014年的52.5%升至2015-2016年的73.3%。
  • 照护链接比例从15.7%升至51.8%,治疗比例从12.0%升至44.7%,均显著增加。
  • 西班牙裔与较低照护链接相关,曼哈顿居住与改善的照护链接相关。
  • documented和估计的未满足治疗需求下降但仍高。

临床怎么用

  • 在阿片类药物治疗项目中实施反射性定性HCV病毒载量检测可改善照护连续结局。
  • 需关注西班牙裔等链接照护较低的人群,并扩大HCV治疗覆盖以控制PWUD中疫情。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis C virus (HCV) remains endemic among people who use drugs (PWUD). Measures of HCV community viral load (CVL) and HCV care continuum outcomes may be valuable for ascertaining unmet treatment need and for HCV surveillance and control. METHODS: Data from patients in an opioid treatment program during 2013-2016 were used to (1) identify proportions of antibody and viral load (VL) tested, linked-to-care, and treated, in 2013-2014 and 2015-2016, and pre- and postimplementation of qualitative reflex VL testing; (2) calculate engaged-in-care HCV CVL and "documented" and "estimated" unmet treatment need; and (3) examine factors associated with linkage-to-HCV-care. RESULTS: Among 11 267 patients, proportions of HCV antibody tested (52.5% in 2013-2014 vs 73.3% in 2015-2016), linked-to-HCV-care (15.7% vs 51.8%), and treated (12.0% vs 44.7%) all increased significantly. Hispanic ethnicity was associated with less linkage-to-care, and Manhattan residence was associated with improved linkage-to-care. The overall engaged-in-care HCV CVL was 4 351 079 copies/mL (standard deviation = 7 149 888); local HCV CVLs varied by subgroup and geography. Documented and estimated unmet treatment need decreased but remained high. CONCLUSIONS: After qualitative reflex VL testing was implemented, care continuum outcomes improved, but gaps remained. High rates of unmet treatment need suggest that control of the HCV epidemic among PWUD will require expansion of HCV treatment coverage.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Jordan AE, Cleland CM, Schackman BR, et al. Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program. J Infect Dis. 2020. PMID: 32877560. doi:10.1093/infdis/jiz686

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。